Clinical Trials Directory

Trials / Completed

CompletedNCT05803811

Effect of Colon Delivered Vitamin B2 on Gut Microbiota and Related Health Biomarkers in Healthy Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
348 (actual)
Sponsor
dsm-firmenich Switzerland AG · Industry
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this intervention study (clinical trial) is to investigate the effect of colon-delivered Riboflavin (vitamin B2) on the faecal microbial composition and diversity in older healthy subjects (50 -70 years of age)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRiboflavinColon delivered vitamin B2 (Riboflavin) for 12 weeks

Timeline

Start date
2022-12-12
Primary completion
2023-07-06
Completion
2023-07-06
First posted
2023-04-07
Last updated
2025-01-17

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT05803811. Inclusion in this directory is not an endorsement.

Effect of Colon Delivered Vitamin B2 on Gut Microbiota and Related Health Biomarkers in Healthy Older Adults (NCT05803811) · Clinical Trials Directory